Concepedia

Aparna Padhye

AP

Statistics

Publications

7

Citations

333

H-Index

7

Active since

2019

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Rice University

Aparna Padhye is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer progression.

ORCID

Publications per year

2019–2025

7

Publications

7

Development, characterization, and applications of multi-material stereolithography bioprinting

Bagrat Grigoryan, Daniel W. Sazer, Amanda Avila et al. · Scientific Reports · 2021 · 156 citations · Full text

, , +17

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

David H. Peng, B. Leticia Rodriguez, Lixia Diao et al. · Nature Communications · 2021 · 70 citations · Full text

, , +17

Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC

Jessica Konen, B. Leticia Rodriguez, Aparna Padhye et al. · Cancer Research · 2021 · 30 citations · Full text

, , +17

A novel ex vivo tumor system identifies Src-mediated invasion and metastasis in mesenchymal tumor cells in non-small cell lung cancer

Aparna Padhye, Christin Ungewiss, Jared J. Fradette et al. · Scientific Reports · 2019 · 28 citations · Full text

, , +17

Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer

Aparna Padhye, Jessica Konen, B. Leticia Rodriguez et al. · JCI Insight · 2021 · 18 citations · Full text

, , +17

1–5 of 7